Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment Meeting Abstract
| Authors: | Von Stackelberg, A.; Locatelli, F.; Zugmaier, G.; Handgretinger, R.; Trippett, T. M.; Rizzari, C.; Zwaan, C. M.; Bhojwani, D.; DuBois, S. G.; Bader, P.; Borkhardt, A.; O'brien, M.; Rheingold, S. R.; Cooper, T. M.; Hu, K. L.; Mergen, N.; Fischer, A.; Zhu, M.; Hijazi, Y.; Whitlock, J.; Gore, L. |
| Abstract Title: | Phase 1/2 study in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL) receiving blinatumomab treatment |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349242704056 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.2292.2292 |
| Notes: | Meeting Abstract: 3703 -- Source: Wos |
